{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:39:33Z","timestamp":1793111973152,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T00:00:00Z","timestamp":1344816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1746-1596-7-97","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T12:14:01Z","timestamp":1344860041000},"source":"Crossref","is-referenced-by-count":99,"title":["Expression of ck-19, galectin-3 and hbme-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis"],"prefix":"10.1186","volume":"7","author":[{"given":"Leandro Luongo","family":"de Matos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Braz","family":"Del Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Ogawa","family":"Matsubayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"de Lima Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auro","family":"Del Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida","family":"da Silva Pinhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,13]]},"reference":[{"key":"636_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin. 2010, 60: 277-300. 10.3322\/caac.20073.","journal-title":"CA Cancer J Clin"},{"key":"636_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1746-1596-7-63","volume":"7","author":"B Gonzalez-Yebra","year":"2012","unstructured":"Gonzalez-Yebra B, Peralta R, Gonzalez AL, Ayala-Garcia MA, de Zarate ME O, Salcedo M: Genetic alterations in a primary medullary thyroid carcinoma and its lymph node metastasis in a patient with 15 years follow-up. Diagn Pathol. 2012, 7: 63-10.1186\/1746-1596-7-63.","journal-title":"Diagn Pathol"},{"key":"636_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF03343959","volume":"25","author":"S Peccin","year":"2002","unstructured":"Peccin S, de Castsro JA, Furlanetto TW, Furtado AP, Brasil BA, Czepielewski MA: Ultrasonography: is it useful in the diagnosis of cancer in thyroid nodules?. J Endocrinol Invest. 2002, 25: 39-43.","journal-title":"J Endocrinol Invest"},{"key":"636_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1590\/S0004-27302004000100012","volume":"48","author":"EK Tomimori","year":"2004","unstructured":"Tomimori EK, Bisi H, Medeiros-Neto G, Camargo RY: Ultrasonographic evaluation of thyroid nodules: comparison with cytologic and histologic diagnosis. Arq Bras Endocrinol Metabol. 2004, 48: 105-113.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"636_CR5","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1056\/NEJMp058061","volume":"352","author":"RD Utiger","year":"2005","unstructured":"Utiger RD: The multiplicity of thyroid nodules and carcinomas. N Engl J Med. 2005, 352: 2376-2378. 10.1056\/NEJMp058061.","journal-title":"N Engl J Med"},{"key":"636_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJM199801293380506","volume":"338","author":"MJ Schlumberger","year":"1998","unstructured":"Schlumberger MJ: Papillary and follicular thyroid carcinoma. N Engl J Med. 1998, 338: 297-306. 10.1056\/NEJM199801293380506.","journal-title":"N Engl J Med"},{"key":"636_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/01.pap.0000138143.34505.02","volume":"11","author":"VA LiVolsi","year":"2004","unstructured":"LiVolsi VA, Baloch ZW: Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol. 2004, 11: 279-287. 10.1097\/01.pap.0000138143.34505.02.","journal-title":"Adv Anat Pathol"},{"key":"636_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jso.20186","volume":"89","author":"MA Zeiger","year":"2005","unstructured":"Zeiger MA, Dackiw AP: Follicular thyroid lesions, elements that affect both diagnosis and prognosis. J Surg Oncol. 2005, 89: 108-113. 10.1002\/jso.20186.","journal-title":"J Surg Oncol"},{"key":"636_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1590\/S0004-27302004000100013","volume":"48","author":"SE Matsuo","year":"2004","unstructured":"Matsuo SE, Martins L, Leoni SG, Hajjar D, Ricarte-Filho JC, Ebina KN, Kimura ET: Biological markers in thyroid tumors. Arq Bras Endocrinol Metabol. 2004, 48: 114-125.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"636_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1385\/EP:17:3:225","volume":"17","author":"JE Barroeta","year":"2006","unstructured":"Barroeta JE, Baloch ZW, Lal P, Pasha TL, Zhang PJ, LiVolsi VA: Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis. Endocr Pathol. 2006, 17: 225-234. 10.1385\/EP:17:3:225.","journal-title":"Endocr Pathol"},{"key":"636_CR11","volume-title":"N Engl J Med","author":"EK Alexander","year":"2012","unstructured":"Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, Friedman L, Kloos RT, Livolsi VA, Mandel SJ, et al.: Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology. N Engl J Med. 2012, Epub ahead of print"},{"key":"636_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2288-6-31","volume":"6","author":"J Zamora","year":"2006","unstructured":"Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A: Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006, 6: 31-10.1186\/1471-2288-6-31.","journal-title":"BMC Med Res Methodol"},{"key":"636_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.athoracsur.2004.09.040","volume":"79","author":"CM Jones","year":"2005","unstructured":"Jones CM, Athanasiou T: Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg. 2005, 79: 16-20. 10.1016\/j.athoracsur.2004.09.040.","journal-title":"Ann Thorac Surg"},{"key":"636_CR14","first-page":"2832","volume":"123","author":"Z Hong","year":"2010","unstructured":"Hong Z, Qi JP, Wang YW, Song YJ, Zhang ZY: Hyalinizing trabecular tumor and papillary carcinoma of the thyroid. Chin Med J (Engl). 2010, 123: 2832-2835.","journal-title":"Chin Med J (Engl)"},{"key":"636_CR15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1136\/jcp.2010.076901","volume":"63","author":"X Zhu","year":"2010","unstructured":"Zhu X, Sun T, Lu H, Zhou X, Lu Y, Cai X: Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma. J Clin Pathol. 2010, 63: 786-789. 10.1136\/jcp.2010.076901.","journal-title":"J Clin Pathol"},{"key":"636_CR16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3346\/jkms.2007.22.4.621","volume":"22","author":"YJ Park","year":"2007","unstructured":"Park YJ, Kwak SH, Kim DC, Kim H, Choe G, do Park J, Jang HC, Park SH, Cho BY, Park SY: Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules. J Korean Med Sci. 2007, 22: 621-628. 10.3346\/jkms.2007.22.4.621.","journal-title":"J Korean Med Sci"},{"key":"636_CR17","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1309\/044V86JN2W3CN5YB","volume":"126","author":"T Scognamiglio","year":"2006","unstructured":"Scognamiglio T, Hyjek E, Kao J, Chen YT: Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma. Am J Clin Pathol. 2006, 126: 700-708. 10.1309\/044V86JN2W3CN5YB.","journal-title":"Am J Clin Pathol"},{"key":"636_CR18","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1038\/modpathol.3800705","volume":"19","author":"MR Nasr","year":"2006","unstructured":"Nasr MR, Mukhopadhyay S, Zhang S, Katzenstein AL: Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: Utility of HBME1 combined with CK19 immunostaining. Mod Pathol. 2006, 19: 1631-1637. 10.1038\/modpathol.3800705.","journal-title":"Mod Pathol"},{"key":"636_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/modpathol.3800235","volume":"18","author":"ML Prasad","year":"2005","unstructured":"Prasad ML, Pellegata NS, Huang Y, Nagaraja HN, de la Chapelle A, Kloos RT: Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol. 2005, 18: 48-57. 10.1038\/modpathol.3800235.","journal-title":"Mod Pathol"},{"key":"636_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2310\/7070.2003.11429","volume":"32","author":"BR Cameron","year":"2003","unstructured":"Cameron BR, Berean KW: Cytokeratin subtypes in thyroid tumours: immunohistochemical study with emphasis on the follicular variant of papillary carcinoma. J Otolaryngol. 2003, 32: 319-322. 10.2310\/7070.2003.11429.","journal-title":"J Otolaryngol"},{"key":"636_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1385\/EP:14:1:55","volume":"14","author":"MB Casey","year":"2003","unstructured":"Casey MB, Lohse CM, Lloyd RV: Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1. Endocr Pathol. 2003, 14: 55-60. 10.1385\/EP:14:1:55.","journal-title":"Endocr Pathol"},{"key":"636_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1385\/EP:13:3:207","volume":"13","author":"S Erkilic","year":"2002","unstructured":"Erkilic S, Aydin A, Kocer NE: Diagnostic utility of cytokeratin 19 expression in multinodular goiter with papillary areas and papillary carcinoma of thyroid. Endocr Pathol. 2002, 13: 207-211. 10.1385\/EP:13:3:207.","journal-title":"Endocr Pathol"},{"key":"636_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1309\/6D9D-7JCM-X4T5-NNJY","volume":"116","author":"S Sahoo","year":"2001","unstructured":"Sahoo S, Hoda SA, Rosai J, DeLellis RA: Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution. Am J Clin Pathol. 2001, 116: 696-702. 10.1309\/6D9D-7JCM-X4T5-NNJY.","journal-title":"Am J Clin Pathol"},{"key":"636_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/modpathol.3880312","volume":"14","author":"CC Cheung","year":"2001","unstructured":"Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL: Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol. 2001, 14: 338-342. 10.1038\/modpathol.3880312.","journal-title":"Mod Pathol"},{"key":"636_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12022-010-9114-y","volume":"21","author":"F Barut","year":"2010","unstructured":"Barut F, Onak Kandemir N, Bektas S, Bahadir B, Keser S, Ozdamar SO: Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19. Endocr Pathol. 2010, 21: 80-89. 10.1007\/s12022-010-9114-y.","journal-title":"Endocr Pathol"},{"key":"636_CR26","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1245\/s10434-008-0034-8","volume":"15","author":"SM Wiseman","year":"2008","unstructured":"Wiseman SM, Melck A, Masoudi H, Ghaidi F, Goldstein L, Gown A, Jones SJ, Griffith OL: Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis. Ann Surg Oncol. 2008, 15: 2811-2826. 10.1245\/s10434-008-0034-8.","journal-title":"Ann Surg Oncol"},{"key":"636_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1530\/EJE-07-0492","volume":"158","author":"YY Liu","year":"2008","unstructured":"Liu YY, Morreau H, Kievit J, Romijn JA, Carrasco N, Smit JW: Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium\/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma. Eur J Endocrinol. 2008, 158: 375-384. 10.1530\/EJE-07-0492.","journal-title":"Eur J Endocrinol"},{"key":"636_CR28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.humpath.2007.07.015","volume":"39","author":"KM Murphy","year":"2008","unstructured":"Murphy KM, Chen F, Clark DP: Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling. Hum Pathol. 2008, 39: 420-426. 10.1016\/j.humpath.2007.07.015.","journal-title":"Hum Pathol"},{"key":"636_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1385\/EP:17:3:213","volume":"17","author":"N Nakamura","year":"2006","unstructured":"Nakamura N, Erickson LA, Jin L, Kajita S, Zhang H, Qian X, Rumilla K, Lloyd RV: Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma. Endocr Pathol. 2006, 17: 213-223. 10.1385\/EP:17:3:213.","journal-title":"Endocr Pathol"},{"key":"636_CR30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1365-2559.2006.02428.x","volume":"48","author":"ED Rossi","year":"2006","unstructured":"Rossi ED, Raffaelli M, Mule A, Miraglia A, Lombardi CP, Vecchio FM, Fadda G: Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid. Histopathology. 2006, 48: 795-800. 10.1111\/j.1365-2559.2006.02428.x.","journal-title":"Histopathology"},{"key":"636_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1677\/erc.1.00944","volume":"12","author":"E Saggiorato","year":"2005","unstructured":"Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos AP, Orlandi F, Papotti M: Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer. 2005, 12: 305-317. 10.1677\/erc.1.00944.","journal-title":"Endocr Relat Cancer"},{"key":"636_CR32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1046\/j.1365-2559.2002.01442.x","volume":"41","author":"MF Beesley","year":"2002","unstructured":"Beesley MF, McLaren KM: Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology. 2002, 41: 236-243. 10.1046\/j.1365-2559.2002.01442.x.","journal-title":"Histopathology"},{"key":"636_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1746-1596-6-126","volume":"6","author":"Q Song","year":"2011","unstructured":"Song Q, Wang D, Lou Y, Li C, Fang C, He X, Li J: Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China. Diagn Pathol. 2011, 6: 126-10.1186\/1746-1596-6-126.","journal-title":"Diagn Pathol"},{"key":"636_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5507\/bp.2008.008","volume":"152","author":"M Rydlova","year":"2008","unstructured":"Rydlova M, Ludvikova M, Stankova I: Potential diagnostic markers in nodular lesions of the thyroid gland: an immunohistochemical study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008, 152: 53-59. 10.5507\/bp.2008.008.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"636_CR35","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/BF03346607","volume":"33","author":"E Raggio","year":"2010","unstructured":"Raggio E, Camandona M, Solerio D, Martino P, Franchello A, Orlandi F, Gasparri G: The diagnostic accuracy of the immunocytochemical markers in the pre-operative evaluation of follicular thyroid lesions. J Endocrinol Invest. 2010, 33: 378-381.","journal-title":"J Endocrinol Invest"},{"key":"636_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.bbrc.2008.09.041","volume":"376","author":"H Inohara","year":"2008","unstructured":"Inohara H, Segawa T, Miyauchi A, Yoshii T, Nakahara S, Raz A, Maeda M, Miyoshi E, Kinoshita N, Yoshida H, et al.: Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies. Biochem Biophys Res Commun. 2008, 376: 605-610. 10.1016\/j.bbrc.2008.09.041.","journal-title":"Biochem Biophys Res Commun"},{"key":"636_CR37","first-page":"36","volume":"20","author":"HA Aiad","year":"2008","unstructured":"Aiad HA, Kandil MA, Asaad NY, El-Kased AM, El-Goday SF: Galectin-3 immunostaining in cytological and histopathological diagnosis of thyroid lesions. J Egypt Natl Canc Inst. 2008, 20: 36-46.","journal-title":"J Egypt Natl Canc Inst"},{"key":"636_CR38","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1677\/ERC-07-0147","volume":"14","author":"MR Sapio","year":"2007","unstructured":"Sapio MR, Guerra A, Posca D, Limone PP, Deandrea M, Motta M, Troncone G, Caleo A, Vallefuoco P, Rossi G, et al.: Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Endocr Relat Cancer. 2007, 14: 1089-1097. 10.1677\/ERC-07-0147.","journal-title":"Endocr Relat Cancer"},{"key":"636_CR39","first-page":"376","volume":"49","author":"M Aron","year":"2006","unstructured":"Aron M, Kapila K, Verma K: Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms. Indian J Pathol Microbiol. 2006, 49: 376-380.","journal-title":"Indian J Pathol Microbiol"},{"key":"636_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000086788","volume":"72","author":"Y Ito","year":"2005","unstructured":"Ito Y, Nakamura Y, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, et al.: Polo-like kinase 1 expression in medullary carcinoma of the thyroid: its relationship with clinicopathological features. Pathobiology. 2005, 72: 186-190. 10.1159\/000086788.","journal-title":"Pathobiology"},{"key":"636_CR41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2559.2005.02221.x","volume":"47","author":"PS de Matos","year":"2005","unstructured":"de Matos PS, Ferreira AP, de Oliveira Facuri F, Assumpcao LV, Metze K, Ward LS: Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology. 2005, 47: 391-401. 10.1111\/j.1365-2559.2005.02221.x.","journal-title":"Histopathology"},{"key":"636_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00428-005-1268-5","volume":"447","author":"B Galusca","year":"2005","unstructured":"Galusca B, Dumollard JM, Lassandre S, Niveleau A, Prades JM, Estour B, Peoc'h M: Global DNA methylation evaluation: potential complementary marker in differential diagnosis of thyroid neoplasia. Virchows Arch. 2005, 447: 18-23. 10.1007\/s00428-005-1268-5.","journal-title":"Virchows Arch"},{"key":"636_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/BF03345351","volume":"28","author":"C Nucera","year":"2005","unstructured":"Nucera C, Mazzon E, Caillou B, Violi MA, Moleti M, Priolo C, Sturniolo G, Puzzolo D, Cavallari V, Trimarchi F, Vermiglio F: Human galectin-3 immunoexpression in thyroid follicular adenomas with cell atypia. J Endocrinol Invest. 2005, 28: 106-112.","journal-title":"J Endocrinol Invest"},{"key":"636_CR44","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1309\/UUQTE505PTN5QJ7M","volume":"122","author":"KB Weber","year":"2004","unstructured":"Weber KB, Shroyer KR, Heinz DE, Nawaz S, Said MS, Haugen BR: The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer. Am J Clin Pathol. 2004, 122: 524-531. 10.1309\/UUQTE505PTN5QJ7M.","journal-title":"Am J Clin Pathol"},{"key":"636_CR45","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/hed.20087","volume":"26","author":"Y Oestreicher-Kedem","year":"2004","unstructured":"Oestreicher-Kedem Y, Halpern M, Roizman P, Hardy B, Sulkes J, Feinmesser R, Stern Y: Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions. Head Neck. 2004, 26: 960-966. 10.1002\/hed.20087.","journal-title":"Head Neck"},{"key":"636_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00428-004-1074-5","volume":"445","author":"M Volante","year":"2004","unstructured":"Volante M, Bozzalla-Cassione F, DePompa R, Saggiorato E, Bartolazzi A, Orlandi F, Papotti M: Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid. Virchows Arch. 2004, 445: 183-188.","journal-title":"Virchows Arch"},{"key":"636_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/106689690401200203","volume":"12","author":"C Torres-Cabala","year":"2004","unstructured":"Torres-Cabala C, Panizo-Santos A, Krutzsch HC, Barazi H, Namba M, Sakaguchi M, Roberts DD, Merino MJ: Differential expression of S100C in thyroid lesions. Int J Surg Pathol. 2004, 12: 107-115. 10.1177\/106689690401200203.","journal-title":"Int J Surg Pathol"},{"key":"636_CR48","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1530\/eje.0.1490449","volume":"149","author":"RB Kovacs","year":"2003","unstructured":"Kovacs RB, Foldes J, Winkler G, Bodo M, Sapi Z: The investigation of galectin-3 in diseases of the thyroid gland. Eur J Endocrinol. 2003, 149: 449-453. 10.1530\/eje.0.1490449.","journal-title":"Eur J Endocrinol"},{"key":"636_CR49","first-page":"111","volume":"54","author":"M Jakubiak-Wielganowicz","year":"2003","unstructured":"Jakubiak-Wielganowicz M, Kubiak R, Sygut J, Pomorski L, Kordek R: Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma. Pol J Pathol. 2003, 54: 111-115.","journal-title":"Pol J Pathol"},{"key":"636_CR50","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1089\/105072503768499662","volume":"13","author":"R Giannini","year":"2003","unstructured":"Giannini R, Faviana P, Cavinato T, Elisei R, Pacini F, Berti P, Fontanini G, Ugolini C, Camacci T, De Ieso K, et al.: Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens. Thyroid. 2003, 13: 765-770. 10.1089\/105072503768499662.","journal-title":"Thyroid"},{"key":"636_CR51","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1210\/jc.2002-021907","volume":"88","author":"MN Nikiforova","year":"2003","unstructured":"Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW, Tallini G, Kroll TG, Nikiforov YE: RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab. 2003, 88: 2318-2326. 10.1210\/jc.2002-021907.","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR52","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/00000478-200304000-00009","volume":"27","author":"RL Gaffney","year":"2003","unstructured":"Gaffney RL, Carney JA, Sebo TJ, Erickson LA, Volante M, Papotti M, Lloyd RV: Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland. Am J Surg Pathol. 2003, 27: 494-498. 10.1097\/00000478-200304000-00009.","journal-title":"Am J Surg Pathol"},{"key":"636_CR53","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1210\/jc.2002-020094","volume":"87","author":"L Martins","year":"2002","unstructured":"Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU, Kimura ET: Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. J Clin Endocrinol Metab. 2002, 87: 4806-4810. 10.1210\/jc.2002-020094.","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR54","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1046\/j.1365-2559.2002.01304.x","volume":"40","author":"A Coli","year":"2002","unstructured":"Coli A, Bigotti G, Zucchetti F, Negro F, Massi G: Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology. 2002, 40: 80-87. 10.1046\/j.1365-2559.2002.01304.x.","journal-title":"Histopathology"},{"key":"636_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1385\/EP:12:3:275","volume":"12","author":"MC Nascimento","year":"2001","unstructured":"Nascimento MC, Bisi H, Alves VA, Longatto-Filho A, Kanamura CT, Medeiros-Neto G: Differential reactivity for galectin-3 in Hurthle cell adenomas and carcinomas. Endocr Pathol. 2001, 12: 275-279. 10.1385\/EP:12:3:275.","journal-title":"Endocr Pathol"},{"key":"636_CR56","doi-asserted-by":"publisher","first-page":"e20665","DOI":"10.1371\/journal.pone.0020665","volume":"6","author":"L Lavra","year":"2011","unstructured":"Lavra L, Rinaldo C, Ulivieri A, Luciani E, Fidanza P, Giacomelli L, Bellotti C, Ricci A, Trovato M, Soddu S, et al.: The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas. PLoS One. 2011, 6: e20665-10.1371\/journal.pone.0020665.","journal-title":"PLoS One"},{"key":"636_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1365-2559.2002.01315.x","volume":"40","author":"KT Mai","year":"2002","unstructured":"Mai KT, Bokhary R, Yazdi HM, Thomas J, Commons AS: Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hurthle cell and\/or apocrine-like changes. Histopathology. 2002, 40: 133-142. 10.1046\/j.1365-2559.2002.01315.x.","journal-title":"Histopathology"},{"key":"636_CR58","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00423-010-0690-6","volume":"395","author":"A Ozolins","year":"2010","unstructured":"Ozolins A, Narbuts Z, Strumfa I, Volanska G, Gardovskis J: Diagnostic utility of immunohistochemical panel in various thyroid pathologies. Langenbecks Arch Surg. 2010, 395: 885-891. 10.1007\/s00423-010-0690-6.","journal-title":"Langenbecks Arch Surg"},{"key":"636_CR59","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1177\/147323000903700339","volume":"37","author":"HS Liang","year":"2009","unstructured":"Liang HS, Zhong YH, Luo ZJ, Huang Y, Lin HD, Luo M, Su HX, Zhou SB, Xie KQ: Comparative analysis of protein expression in differentiated thyroid tumours: a multicentre study. J Int Med Res. 2009, 37: 927-938.","journal-title":"J Int Med Res"},{"key":"636_CR60","first-page":"179","volume":"25","author":"Y Ito","year":"2005","unstructured":"Ito Y, Yoshida H, Tomoda C, Miya A, Kobayashi K, Matsuzuka F, Kakudo K, Kuma K, Miyauchi A: HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma. Anticancer Res. 2005, 25: 179-182.","journal-title":"Anticancer Res"},{"key":"636_CR61","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1507\/endocrj.50.173","volume":"50","author":"T Mase","year":"2003","unstructured":"Mase T, Funahashi H, Koshikawa T, Imai T, Nara Y, Tanaka Y, Nakao A: HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm. Endocr J. 2003, 50: 173-177. 10.1507\/endocrj.50.173.","journal-title":"Endocr J"},{"key":"636_CR62","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cncy.20082","volume":"118","author":"AC Schmitt","year":"2010","unstructured":"Schmitt AC, Cohen C, Siddiqui MT: Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: diagnostic utility. Cancer Cytopathol. 2010, 118: 196-202. 10.1002\/cncy.20082.","journal-title":"Cancer Cytopathol"},{"key":"636_CR63","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1159\/000325595","volume":"52","author":"M Bonzanini","year":"2008","unstructured":"Bonzanini M, Amadori PL, Sagramoso C, Dalla Palma P: Expression of cytokeratin 19 and protein p63 in fine needle aspiration biopsy of papillary thyroid carcinoma. Acta Cytol. 2008, 52: 541-548. 10.1159\/000325595.","journal-title":"Acta Cytol"},{"key":"636_CR64","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1089\/thy.2009.0282","volume":"20","author":"L Torregrossa","year":"2010","unstructured":"Torregrossa L, Faviana P, Filice ME, Materazzi G, Miccoli P, Vitti P, Fontanini G, Melillo RM, Santoro M, Basolo F: CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1. Thyroid. 2010, 20: 495-504. 10.1089\/thy.2009.0282.","journal-title":"Thyroid"},{"key":"636_CR65","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1159\/000325381","volume":"53","author":"G Pennelli","year":"2009","unstructured":"Pennelli G, Mian C, Pelizzo MR, Naccamulli D, Piotto A, Girelli ME, Mescoli C, Rugge M: Galectin-3 cytotest in thyroid follicular neoplasia: a prospective, monoinstitutional study. Acta Cytol. 2009, 53: 533-539. 10.1159\/000325381.","journal-title":"Acta Cytol"},{"key":"636_CR66","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/PAI.0b013e31818935a9","volume":"17","author":"C Franco","year":"2009","unstructured":"Franco C, Martinez V, Allamand JP, Medina F, Glasinovic A, Osorio M, Schachter D: Molecular markers in thyroid fine-needle aspiration biopsy: a prospective study. Appl Immunohistochem Mol Morphol. 2009, 17: 211-215. 10.1097\/PAI.0b013e31818935a9.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"636_CR67","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1470-2045(08)70132-3","volume":"9","author":"A Bartolazzi","year":"2008","unstructured":"Bartolazzi A, Orlandi F, Saggiorato E, Volante M, Arecco F, Rossetto R, Palestini N, Ghigo E, Papotti M, Bussolati G, et al.: Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol. 2008, 9: 543-549. 10.1016\/S1470-2045(08)70132-3.","journal-title":"Lancet Oncol"},{"key":"636_CR68","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/sj.bjc.6603232","volume":"95","author":"A Carpi","year":"2006","unstructured":"Carpi A, Naccarato AG, Iervasi G, Nicolini A, Bevilacqua G, Viacava P, Collecchi P, Lavra L, Marchetti C, Sciacchitano S, Bartolazzi A: Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology. Br J Cancer. 2006, 95: 204-209. 10.1038\/sj.bjc.6603232.","journal-title":"Br J Cancer"},{"key":"636_CR69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000325891","volume":"50","author":"MJ Kim","year":"2006","unstructured":"Kim MJ, Kim HJ, Hong SJ, Shong YK, Gong G: Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions. Acta Cytol. 2006, 50: 28-34. 10.1159\/000325891.","journal-title":"Acta Cytol"},{"key":"636_CR70","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.bjc.6602822","volume":"93","author":"JF Collet","year":"2005","unstructured":"Collet JF, Hurbain I, Prengel C, Utzmann O, Scetbon F, Bernaudin JF, Fajac A: Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples. Br J Cancer. 2005, 93: 1175-1181. 10.1038\/sj.bjc.6602822.","journal-title":"Br J Cancer"},{"key":"636_CR71","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/dc.20156","volume":"31","author":"J Maruta","year":"2004","unstructured":"Maruta J, Hashimoto H, Yamashita H, Noguchi S: Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma. Diagn Cytopathol. 2004, 31: 392-396. 10.1002\/dc.20156.","journal-title":"Diagn Cytopathol"},{"key":"636_CR72","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/dc.10111","volume":"26","author":"Y Aratake","year":"2002","unstructured":"Aratake Y, Umeki K, Kiyoyama K, Hinoura Y, Sato S, Ohno A, Kuribayashi T, Hirai K, Nabeshima K, Kotani T: Diagnostic utility of galectin-3 and CD26\/DPPIV as preoperative diagnostic markers for thyroid nodules. Diagn Cytopathol. 2002, 26: 366-372. 10.1002\/dc.10111.","journal-title":"Diagn Cytopathol"},{"key":"636_CR73","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(00)04817-0","volume":"357","author":"A Bartolazzi","year":"2001","unstructured":"Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, et al.: Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet. 2001, 357: 1644-1650. 10.1016\/S0140-6736(00)04817-0.","journal-title":"Lancet"},{"key":"636_CR74","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/cncr.21026","volume":"105","author":"ED Rossi","year":"2005","unstructured":"Rossi ED, Raffaelli M, Minimo C, Mule A, Lombardi CP, Vecchio FM, Fadda G: Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration biopsies. Cancer. 2005, 105: 87-95. 10.1002\/cncr.21026.","journal-title":"Cancer"},{"key":"636_CR75","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF03351054","volume":"27","author":"E Saggiorato","year":"2004","unstructured":"Saggiorato E, Aversa S, Deandreis D, Arecco F, Mussa A, Puligheddu B, Cappia S, Conticello S, Papotti M, Orlandi F: Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas. J Endocrinol Invest. 2004, 27: 311-317.","journal-title":"J Endocrinol Invest"},{"key":"636_CR76","first-page":"348","volume":"38","author":"T Mijovic","year":"2009","unstructured":"Mijovic T, Gologan O, Rochon L, Hier M, Black MJ, Young J, Rivera J, Tamilia M, Payne RJ: Fine-needle aspiration biopsy of the thyroid: review of cytopathologic features predictive of malignancy. J Otolaryngol Head Neck Surg. 2009, 38: 348-354.","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"636_CR77","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/sj.bjc.6604194","volume":"98","author":"C de Micco","year":"2008","unstructured":"de Micco C, Savchenko V, Giorgi R, Sebag F, Henry JF: Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV. Br J Cancer. 2008, 98: 818-823. 10.1038\/sj.bjc.6604194.","journal-title":"Br J Cancer"},{"key":"636_CR78","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/dc.20132","volume":"31","author":"T Giorgadze","year":"2004","unstructured":"Giorgadze T, Rossi ED, Fadda G, Gupta PK, Livolsi VA, Baloch Z: Does the fine-needle aspiration diagnosis of \"Hurthle-cell neoplasm\/follicular neoplasm with oncocytic features\" denote increased risk of malignancy?. Diagn Cytopathol. 2004, 31: 307-312. 10.1002\/dc.20132.","journal-title":"Diagn Cytopathol"},{"key":"636_CR79","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.surg.2005.06.047","volume":"138","author":"DI Alaedeen","year":"2005","unstructured":"Alaedeen DI, Khiyami A, McHenry CR: Fine-needle aspiration biopsy specimen with a predominance of Hurthle cells: a dilemma in the management of nodular thyroid disease. Surgery. 2005, 138: 650-656. 10.1016\/j.surg.2005.06.047. discussion 656\u2013657","journal-title":"Surgery"},{"key":"636_CR80","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mce.2010.01.010","volume":"322","author":"M Eszlinger","year":"2010","unstructured":"Eszlinger M, Paschke R: Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol Cell Endocrinol. 2010, 322: 29-37. 10.1016\/j.mce.2010.01.010.","journal-title":"Mol Cell Endocrinol"},{"key":"636_CR81","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.suc.2009.06.012","volume":"89","author":"MA Kato","year":"2009","unstructured":"Kato MA, Fahey TJ: Molecular markers in thyroid cancer diagnostics. Surg Clin North Am. 2009, 89: 1139-1155. 10.1016\/j.suc.2009.06.012.","journal-title":"Surg Clin North Am"},{"key":"636_CR82","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/S0046-8177(99)90033-3","volume":"30","author":"ZW Baloch","year":"1999","unstructured":"Baloch ZW, Abraham S, Roberts S, LiVolsi VA: Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility. Hum Pathol. 1999, 30: 1166-1171. 10.1016\/S0046-8177(99)90033-3.","journal-title":"Hum Pathol"},{"key":"636_CR83","first-page":"787","volume":"18","author":"T Yoshii","year":"2001","unstructured":"Yoshii T, Inohara H, Takenaka Y, Honjo Y, Akahani S, Nomura T, Raz A, Kubo T: Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. Int J Oncol. 2001, 18: 787-792.","journal-title":"Int J Oncol"},{"key":"636_CR84","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/thy.2007.0361","volume":"18","author":"S Saussez","year":"2008","unstructured":"Saussez S, Glinoer D, Chantrain G, Pattou F, Carnaille B, Andre S, Gabius HJ, Laurent G: Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease. Thyroid. 2008, 18: 705-712. 10.1089\/thy.2007.0361.","journal-title":"Thyroid"},{"key":"636_CR85","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/dc.20841","volume":"36","author":"ME Nga","year":"2008","unstructured":"Nga ME, Lim GS, Soh CH, Kumarasinghe MP: HBME-1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma. Diagn Cytopathol. 2008, 36: 550-556. 10.1002\/dc.20841.","journal-title":"Diagn Cytopathol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-7-97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1746-1596-7-97\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-7-97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T19:17:59Z","timestamp":1548098279000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/1746-1596-7-97"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,13]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1186\/1746-1596-7-97","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,13]]},"article-number":"97"}}